Melanoma Genetic Risk Test Price | Lahalak Medical Platform

Protect your future by identifying genetic mutations linked to melanoma. This screening is vital for individuals with a family history to implement early detection and personalized prevention strategies.

Scientific name: Melanoma Genetic Risk Panel (CDKN2A/CDK4)

An advanced genetic test analyzing CDKN2A and CDK4 mutations to determine hereditary risk for melanoma. It enables early detection and proactive monitoring for high-risk individuals and families.

Melanoma Genetic Risk Panel (CDKN2A/CDK4) - Assess Your Genetic Melanoma Risk
Service type Genetic Analysis
Duration 15-20 minutes
Fasting Fasting is not required

Included Services

  • Blood or saliva sample collection
  • CDKN2A mutation analysis
  • CDK4 mutation analysis
  • Detailed genetic report

Medical Service Information

Importance of Genetic Testing

  • Determines hereditary risk for developing melanoma.
  • Empowers family members to take early preventive actions.
  • Guides clinicians in establishing intensive dermatological surveillance.

Who Should Get Tested?

  • Individuals with two or more close relatives diagnosed with melanoma.
  • Patients with multiple primary melanoma diagnoses.
  • Families with a combined history of melanoma and pancreatic cancer.

Understanding Your Results

  • Positive result: Indicates a mutation that increases risk, not a current cancer diagnosis.
  • Negative result: Does not eliminate all risk but shows the absence of tested mutations.
  • Genetic counseling is highly recommended to discuss clinical implications.

Conditions & Notices

  • Family medical history preferred
  • No prior dietary restrictions required

Medical services you might also like